Otsuka : appoints Board Members and Audit & Supervisory Board Members (194KB)
March 28, 2019 at 02:15 am EDT
Share
March 28, 2019
Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members
Otsuka Holdings Co., Ltd., (Head office: Chiyoda-ku, Tokyo, Japan; President and Representative
Director, CEO: Tatsuo Higuchi) announced the board members and audit & supervisory board members as detailed below were ratified today at the annual general shareholders' meeting and a meeting of its Board of Directors.
Board Members and Audit & Supervisory Board Members
Title
Name
Chairman and Representative Director
Ichiro Otsuka
President and Representative Director, CEO
Tatsuo Higuchi
Senior Managing Director
Yoshiro Matsuo
Executive Director, CFO
Yuko Makino
Executive Director, Business Portfolio Management
Shuichi Takagi
(new appointment)
Executive Director
Sadanobu Tobe
Executive Director
Atsumasa Makise
Executive Director
Masayuki Kobayashi
Executive Director
Noriko Tojo
Outside Director
Yukio Matsutani
Outside Director
Ko Sekiguchi
Outside Director
Yoshihisa Aoki
(new appointment)
Standing Audit & Supervisory Board Member
Yozo Toba
Outside Audit & Supervisory Board Member
Hiroshi Sugawara
Outside Audit & Supervisory Board Member
Yoko Wachi
Outside Audit & Supervisory Board Member
Kazuo Takahashi
*Tadaaki Konose retired as outside director.
Attachments
Original document
Permalink
Disclaimer
Otsuka Holdings Co. Ltd. published this content on 28 March 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 28 March 2019 06:14:15 UTC
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
OTSUKA HOLDINGS CO., LTD. 
